A. Menarini Diagnostics United States of America Canada France Germany Spain United Kingdom

Datenversion: Globocan 2022 (version 1.1) - 08.02.2024

[2] Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Globale Beobachtungsstelle für Krebs: Cancer Today. Lyon, Frankreich: Internationale Agentur für Krebsforschung. Verfügbar unter: https://gco.iarc.who.int/today, accessed [06 August 2024].

Contact: PAVY Consulting, Linda PAVY, lipavy@pavyconsulting.com 

Logo - https://mma.prnewswire.com/media/2499333/Menarini_Diagnostics_and_Nucleix_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/a-menarini-diagnostics-und-nucleix-kundigen-eine-strategische-partnerschaft-fur-einen-nicht-invasiven-blasenkrebstest-in-europa-an-302241252.html